Skip to main content
. 2017 Sep 25;53(4):557–565. doi: 10.1007/s00535-017-1391-5

Fig. 2.

Fig. 2

SVR12 rates for each arm in the ITT-PS, ITT and mITT populations. The error bars represent the 95% confidence intervals based on Wilson’s score method.  Arm A: 8-week G/P treatment; Arm B: 12-week OBV/PTV/r treatment; Arm C: 12-week G/P treatment. SVR sustained virologic response; ITT intent-to-treat; ITT-PS ITT population excluding patients with the NS5A Y93H baseline polymorphism; mITT ITT excluding patients who did not achieve SVR12 for reasons other than virologic failure